The Biden administration believes that including obesity drugs in Medicare coverage will reduce out-of-pocket costs for the ...

A new HHS rule would require Medicare and Medicaid to cover drugs like Wegovy or Zepbound for a large segment of Americans.

The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist (GLP-1 RA) ...

Under Secretary for Health Dr. Shereef Elnahal said Monday the VA needs extra funding to cover the costs of drugs such as ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...

Eli Lilly’s strong position in GLP-1 drugs is overlooked by the market. Find out why LLY stock is a buy even as others pull ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

Access to the medication is limited, especially since medications like Wegovy and Zepbound are not covered by most government ...

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

Donald Trump's health team picks includes outspoken critics of the medical establishment and COVID-19 health measures ...